The Nasdaq Stock Market will list its first cannabis shares on Tuesday, marking a key milestone for an industry that has been rejected by the Trump administration.
Why Marijuana Stocks Aren’t Worth Your Money
Legalized marijuana has a lot of investors having visions of lots of green. With legalization sweeping across the states, it seems to be a great time to invest in marijuana stocks. Unfortunately, it’s not.
MJIC Marijuana Index Gains 18% in January as Market Continues Rally
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, increased 18% in January.
Aurora, Canopy Stock Get a Required Boost with Sweden Marijuana Interest
Two of the top 10 most-traded shares in Sweden in January 2018 were Canada marijuana stocks, adding further proof that the marijuana market is growing more global with each passing day.
Canada’s Small Financial Firms Get Buzz From Weed Stocks
Investors are betting Canada’s smaller financial firms could see a jump in revenues after they helped fund marijuana companies ahead of the country’s planned legalization of the drug this year.
Aurora Stock: What to Expect from the Aurora-CanniMed Ceasefire
Here’s Why Aurora Stock May Survive the Volatility. A simple case of acquisition has turned two marijuana companies—Aurora Cannabis Inc. (TSE: ACB), (OCTMKTS: ACBFF) and CanniMed Therapeutics Inc. (TSE: CMED), OCTMKTS: CMMDF)—into the biggest adversaries
Canadian Marijuana Producers End Rally as U.S. Set to Tighten Enforcement
Canadian cannabis stocks fell on Thursday after the U.S. government said it would resume enforcement of federal laws banning marijuana in states that had legalized pot, disrupting a seven-day rally that boosted shares to record highs.
5 Reasons Cannabis Stocks Were on Fire in 2017
You might be wondering what’s behind the big rally in cannabis stocks? While a generally bullish market has certainly helped, there are five other considerably more prominent reasons behind the rally in marijuana stocks in 2017.
3 Top Marijuana Stocks to Buy Now — Plus 2 Bonus Ideas
Here’s why the marijuana market is so intriguing, how big the opportunity could be, and why these stocks are top stocks to own.
Marijuana Index Gains on Strength of Canadian Cannabis Stocks
A healthy day of trading for Canadian cannabis stocks led the North American Marijuana Index to gain several points over Monday’s 169.07 close.
Aphria Stock Soars After Announcement of Cannabis Deal With Shoppers Drug Mart
Following market close on Dec. 4, 2017, Aphria Inc. (TSX:APH), an Ontario-based licensed producer of medical cannabis, made headlines when it announced that it had entered into an agreement to be the medical cannabis supplier for Shoppers Drug Mart, a Canadian pharmacy chain.
Canada’s Aurora Cannabis Boosts Stake in Australia-Based Cann Group
Canada’s Aurora Cannabis Inc (ACB.TO) said on Monday it increased its stake in Australia-based Cann Group Ltd (CAN.AX) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.
How to Buy Marijuana Stocks Quickly and Easily With This New Fund
The first U.S. exchange-traded fund, ETF, to focus on marijuana stocks is launching Dec. 26 — days before California legalizes recreational cannabis use on January 1.
The Biggest Opportunity Yet to Buy Canopy Growth Corp. Starts Now
Over the past year, investors have been anxiously following the progression of marijuana stocks such as Canopy Growth Corp, which offer the promise of significant growth from the new, emerging segment of the economy.
Deal-Making in the Cannabis Industry Hits an All-Time High
If it seems like there’s been a spurt of deals and potential deals going on in the cannabis industry lately, it’s because that’s exactly what’s happening.
Canada Weed Stocks Come Off High as Challenges Loom Before Legalization
Canada’s weed stocks, which have surrendered some of the potent gains that pushed them to record highs this month, face a bumpy ride in 2018 that could purge smaller players, as the country moves to allow recreational use of cannabis in July.
Say Hello to the Very First Marijuana ETF You Can Buy in the U.S.
Say hello to the very first marijuana ETF for the U.S. As reported by CNBC, on Oct. 27, ETF Managers Group filed for a new ETF, the Alternative Agroscience ETF.
The World’s Largest Marijuana Stock Has Investors Seeing Green
Not surprisingly, Canadian pot stocks have been the top performers of late, with Canopy Growth Corp. (NASDAQOTH:TWMJF), the now-largest marijuana stock in the world by market cap, leading the charge.
Aurora Cannabis Makes Proposal to Acquire Rival Company CanniMed
Vancouver-based Aurora Cannabis Inc. said Tuesday that it has made an all-share offer for CanniMed Therapeutics Inc., a fellow Canadian medical marijuana company.
Manitoba’s Plans for Marijuana Could Create Growth Opportunities
Manitoba’s the latest province to unveil its plan for marijuana sales and distribution, releasing details Tuesday on how the new industry will operate.
Can Any Other Cannabis Stock Measure Up to Canopy Growth?
Shares of Canopy Growth Corp. (TSX:WEED) have climbed a stunning 53.8% month over month as of close on November 1. With all of this in mind, has Canopy established itself as the premier cannabis stock for Canadians?
Why Auscann Group Holdings Ltd Shares Rocketed 27% Higher
The Auscann Group Holdings Ltd (ASX: AC8) share price had a day to remember on Tuesday. At one stage the medicinal cannabis company’s shares were up as much as 27% before finishing the day 23.5% higher at 52.5 cents.
The Double Whammy That Sent Marijuana Stock Insys Therapeutics Crashing
Shares of Insys Therapeutics, a small-cap biotech with a focus on pain management, plunged as much as 30% on Wednesday after receiving a double whammy.
Making the Case for Cannabis as an Ethical Investment
The high-growth industry certainly offers terrific prospects that would be envied by many tech stocks. However, a big hurdle for some investors is investing in “sin stocks,” or what could be perceived as unethical industries and businesses.
Are Canada’s Licensed Marijuana Producers at Risk of Becoming Delisted?
Marijuana stocks were down sharply in Tuesday’s trading as Toronto Stock Exchange operator TMX Group Limited suggested the exchange is going to start cracking down on marijuana producers engaging in illegal activities south of the border.
Shares of Canada’s Aphria Slump as Marijuana Faces Regulatory Risk
Shares of Canadian marijuana company Aphria Inc sank on Tuesday, after the operator of the Toronto Stock Exchange said cannabis companies with U.S. interests would come under heightened scrutiny and could be delisted.
Toronto Stock Exchange May Delist Marijuana Firms With US Operations
Canada’s TMX Group Ltd (X.TO), operator of the Toronto Stock Exchange, said on Monday that it might delist stocks of marijuana companies with interests in the United States, where their operations are illegal under federal law.
What We Know About the Ousting of MassRoots CEO Isaac Dietrich
On Oct. 16, 2017, the Board of Directors for MassRoots (OTCQB:MSRT), a marijuana social media platform, ousted Isaac Dietrich as the company’s Chairman and Chief Executive Officer.
Investing in Marijuana: Cannabis Industry Raises Hit $1.8 Billion
Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.
Has This Top Marijuana Stock Weathered a Serious Storm?
The stock of MedReleaf Corp. has recently outperformed those of other top marijuana stock players in Canada, and there could be further price gains going forward after the recently listed cannabis firm has found its footing and stopped the earlier quarterly revenue declines.
Big Weed is on Board With Trudeau’s Marijuana Tax Plan
Canada’s biggest medical cannabis producers are seeing their stock prices rise after the federal government announced a plan to levy a one dollar per gram tax on recreational marijuana sales.
Pot Investors: This Mistake Cost a Growth Company 35% of its Stock Price!
Marijuana companies should be careful in overselling how much growth will be achieved or what the prospects will look like for the industry. There is a recent example that cannabis investors would be wise to review, and that’s what happened with Freshii Inc..
Zogenix Soars 10% Today Despite Diluting Investors
After the company announced it will tap investors for money to fuel R&D (research and development) and pre-commercialization efforts for its Dravet syndrome drug, shares in Zogenix (NASDAQ: ZGNX) are rallying 10% at 2 p.m. EDT today.
2 Metrics All Cannabis Stock Investors Need to Know
Marijuana stock investors are going to have to keep their eyes on the following two critical data points for each and every marijuana stock they’re considering buying, or that they already own.
Marijuana Index Decreased 11% in August, Cancelling Out July’s Gains
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, decreased 11% in August.
Why More Medical Marijuana IPOs Are Coming
Almost three months after the initial public offering (IPO) of MedReleaf Corp. (TSX:LEAF), shares have yet to do much in either direction. The company, which came to market in what was then described as a “botched IPO,” fell quickly out of the gate from its IPO price.
Why Insys Therapeutics’ Stock Crashed 18.5% in August
Arizona’s attorney general is suing Insys Therapeutics over its marketing of the fentanyl opioid spray, Subsys, and that news caused the company’s shares to tumble 18.5% in August, according to S&P Global Market Intelligence.
The 1 Marijuana Stock That Can Thrive, Even If Jeff Sessions Cracks Down
Undoubtedly, a reversal in the federal government’s laxness on pot would be terrible news for marijuana stock investors, but not every last company would be decimated. One marijuana stock could still thrive, even with Jeff Sessions waving the metaphorical sword at the pot industry: Scotts Miracle-Gro.
Where Are Canadian Cannabis Stocks Headed From Here?
With prices for many major Canadian cannabis stocks such as Canopy Growth Corp., Aphria Inc., and Aurora Cannabis Inc. trading sideways over the past few months, investors are now wondering which direction stocks will move from here, and what the long-term play with this industry is overall.
Why Canopy Growth Corp. Will Become Great Again in the Eyes of Investors
Canopy Growth Corp. (TSX:WEED) was the first cannabis stock to the market and quickly captured the attention of traders and risk-taking growth investors alike. As a result, shares of Canopy skyrocketed 300% in a span of just a few months last year.
Better Know a Marijuana Stock: Cronos Group
Whereas most weed businesses are working harder than ever to increase their grow capacity, Cronos Group is a company that’s trying to work smarter. Based in Canada, Cronos Group is an investment firm that primarily invests in Canadian-based pot companies involved in Canada’s medical-marijuana industry.
Marijuana Firm Says TMX Trade Shift Would Undermine System
Any move by the Toronto Stock Exchange owner to stop settling trades for marijuana companies with U.S. operations would undermine the market’s regulatory system, according to one Canadian pot company.
Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?
TMX Group Ltd. (TSX:X), the operator of the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), has reportedly been speaking with regulators to figure out what will happen to Canadian marijuana producers with assets in the U.S.
GW Pharmaceuticals Plc. Soared 1,030%, with More Gains to Come
GW Pharmaceuticals Plc. is a biopharmaceutical company that discovers, develops, and commercializes cannabinoid prescription medicines. Since May 10, 2013, the stock price has climbed 1,033%.
Up in Smoke: Zynerba Pharmaceuticals Lost More Than Half Its Value
Clinical-stage cannabinoid-based drug developer Zynerba Pharmaceuticals (NASDAQ:ZYNE) had been one of the strongest-performing pot stocks over the trailing year prior to the start of this past week.
TMX Says Lower Trading Volume Mostly Due to Avoidance of Pot Stocks
TMX Group Ltd’s CEO on Thursday brushed off signs that the grip of Canada’s dominant stock exchange operator on overall trading volumes was slipping, saying recent market share losses were mostly due to its rejection of certain listings.
The 1 Word in GW Pharmaceuticals’ Q3 Update That Disappointed Investors
When GW Pharmaceuticals announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. However, it wasn’t any of the numbers in the update that caused this decline. Instead, one word caused investors’ disappointment.
Why the 3 Hottest Weed Stocks of the Summer Could Get Even Hotter
For many weed stocks, the summer of 2017 hasn’t been what you’d call a scorcher. However, three marijuana stocks have sizzled this summer.
Marijuana Index Increases 11% in July as US and Canadian Stocks Rebound
The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the U.S. and Canada, increased 11% in July. This marks the first positive month for the North American Index since January.
Cara Therapeutics May Be 1 Clinical Trial Away From a $1 Billion Valuation
If just a single clinical trial works in favor of Cara Therapeutics, it could regain everything it’s recently lost and possibly hit a $1 billion market cap.